RecruitingPhase 4Drug trialUse of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney DiseaseTo evaluate triple therapy with nsMRA, RASi and SGLT2i on albuminuria in individuals with T2D and CKD